Scribe Therapeutics logo

Scribe Therapeutics

Scribe Therapeutics develops molecular engineering solutions for CRISPR-based genetic medicine.

2

Funding Rounds

$120.0m

Money raised

Overview

Scribe Therapeutics develops molecular engineering solutions for CRISPR-based genetic medicine.